Camelot Portfolios, LLC Biogen Inc. Transaction History

Camelot Portfolios, LLC

$179 Million
Q2 2024

A detailed history of Camelot Portfolios, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Camelot Portfolios, LLC holds 1,900 shares of BIIB stock, worth $330,201. This represents 0.25% of its overall portfolio holdings.

Number of Shares

1,900

Holding current value

$330,201

% of portfolio

0.25%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$190.52 - $236.72 $361,988 - $449,768	1,900 New	1,900 $440,000
Q4 2023 Jan 23, 2024	BUY	$222.59 - $267.94 $200,331 - $241,146	900 Added 81.82%	2,000 $517,000
Q3 2023 Oct 20, 2023	SELL	$253.3 - $285.89 $253,300 - $285,890	-1,000 Reduced 47.62%	1,100 $282,000
Q2 2023 Jul 25, 2023	BUY	$275.25 - $318.06 $275,250 - $318,060	1,000 Added 90.91%	2,100 $598,000
Q1 2023 Apr 20, 2023	BUY	$256.56 - $292.34 $282,216 - $321,574	1,100 New	1,100 $305,000
Q3 2022 Oct 31, 2022	SELL	$194.69 - $268.46 $315,787 - $435,442	-1,622 Reduced 42.63%	2,183 $583,000
Q2 2022 Jul 18, 2022	SELL	$187.54 - $223.02 $191,103 - $227,257	-1,019 Reduced 21.12%	3,805 $776,000
Q1 2022 Apr 20, 2022	BUY	$193.77 - $244.14 $37,785 - $47,607	195 Added 4.21%	4,824 $1.02 Million
Q4 2021 Jan 04, 2022	BUY	$223.92 - $287.77 $152,041 - $195,395	679 Added 17.19%	4,629 $1.11 Million
Q3 2021 Nov 04, 2021	SELL	$282.99 - $369.05 $69,615 - $90,786	-246 Reduced 5.86%	3,950 $1.12 Million
Q2 2021 Jul 28, 2021	SELL	$259.0 - $414.71 $263,403 - $421,760	-1,017 Reduced 19.51%	4,196 $1.45 Million
Q1 2021 Apr 21, 2021	BUY	$242.95 - $284.63 $66,325 - $77,703	273 Added 5.53%	5,213 $1.46 Million
Q4 2020 Jan 27, 2021	BUY	$236.26 - $355.63 $159,002 - $239,338	673 Added 15.77%	4,940 $1.21 Million
Q3 2020 Oct 19, 2020	SELL	$264.77 - $305.71 $126,560 - $146,129	-478 Reduced 10.07%	4,267 $1.21 Million
Q2 2020 Jul 30, 2020	SELL	$258.66 - $342.55 $65,182 - $86,322	-252 Reduced 5.04%	4,745 $1.27 Million
Q1 2020 Apr 28, 2020	SELL	$268.85 - $341.04 $94,635 - $120,046	-352 Reduced 6.58%	4,997 $1.58 Million
Q4 2019 Jan 16, 2020	BUY	$220.06 - $304.07 $2,200 - $3,040	10 Added 0.19%	5,349 $1.59 Million
Q3 2019 Oct 15, 2019	SELL	$217.44 - $243.88 $15,220 - $17,071	-70 Reduced 1.29%	5,339 $1.24 Million
Q2 2019 Jul 19, 2019	BUY	$219.29 - $241.72 $210,518 - $232,051	960 Added 21.58%	5,409 $1.27 Million
Q1 2019 Apr 25, 2019	BUY	$216.71 - $338.96 $598,553 - $936,207	2,762 Added 163.72%	4,449 $1.05 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $142,870 - $180,960	513 Added 43.7%	1,687 $508,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $155,853 - $203,813	-531 Reduced 31.14%	1,174 $415,000
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $439,071 - $523,281	1,705 New	1,705 $495,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camelot Portfolios, LLC with notifications on news.

Account

Camelot Portfolios, LLC Biogen Inc. Transaction History